Results 141 to 150 of about 3,567,577 (243)

Citations to highly-cited researchers by their co-authors and their self-citations: How these factors affect highly-cited researchers' h-index in Scopus

, 2011
Leila Dehghani, Reza Basirian Jahromi, Mazyar Ganjoo   +2 more
openalex   +1 more source

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source

Identification of a Kingella kingae factor H binding protein that is the major determinant of serum resistance. [PDF]

PLoS Pathog
Hernandez KA, Porsch EA, Muñoz VL, St Geme Iii JW.   +3 more
europepmc   +1 more source

THE CO-TO-H₂CONVERSION FACTOR FROM INFRARED DUST EMISSION ACROSS THE LOCAL GROUP [PDF]

, 2011
Adam K. Leroy, Alberto Bolatto, Karl Gordon, Karin Sandstrom, Pierre Gratier, Erik Rosolowsky, Charles W. Engelbracht, Norikazu Mizuno, Edvige Corbelli, Yasuo Fukui, Akiko Kawamura   +10 more
openalex   +1 more source

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

Molecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici, Soheil Akbari, Ceyda Caliskan, Canan Celiker, Ozden Oz, Leman Binokay, Gökhan Karakulah, Serif Senturk, Esra Erdal   +8 more
wiley   +1 more source

Differential modulation of SARS-CoV-2 infection by complement factor H and properdin. [PDF]

Front Immunol
Kishore U, Varghese PM, Kumar C, Idicula-Thomas S, Mayora Neto M, Tsolaki AG, Ponnachan P, Masmoudi K, Al-Ramadi B, Vatish M, Madan T, Temperton N, Beirag N.   +12 more
europepmc   +1 more source

Interleukin-10 Modifies the Effects of Interleukin-1β and Tumor Necrosis Factor-α on the Activity and Expression of Prostaglandin H Synthase-2 and the NAD⁺-Dependent 15-Hydroxyprostaglandin Dehydrogenase in Cultured Term Human Villous Trophoblast and Chorion Trophoblast Cells¹ [PDF]

, 1999
Francesco Pomini, Alessandro Caruso, John Challis   +2 more
openalex   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Factor H: a novel modulator in sickle cell disease

Haematologica, 2019
Wassim El Nemer, Bérengère Koehl
doaj   +1 more source

Disease Progression in Age-Related Macular Degeneration Patients Carrying Rare Variants in the Complement Factor H or Complement Factor I Genes. [PDF]

Invest Ophthalmol Vis Sci
Cinque F, de Breuk A, Mhmud H, De Jong S, Vermeulen J, Liefers B, den Hollander AI, Thee E, Colijn JM, Heesterbeek TJ, Klaver CC, Hoyng CB, Lechanteur YTE.   +12 more
europepmc   +1 more source